THE REAL ALEX JONES | PART 2

Dr. Tina Peers, functional medicine physician, explains her clinical concern that the body may struggle to clear COVID-19 spike protein on its own. Whether from infection or injection, spike protein binds to ACE2 receptors found throughout the body, in the brain, heart, arteries, lungs, and reproductive system, potentially driving chronic inflammation. Standard tests, she notes, often come back normal even in severely symptomatic patients, making diagnosis and treatment especially difficult.

Dr. Peers has spent years treating mast cell activation syndrome (MCAS) — a condition affecting an estimated 20% of the population involving overreactive immune cells that, when triggered, can release a cascade of inflammatory chemicals throughout the body. She shares her clinical hypothesis that MCAS may be a significant factor underlying many long Covid cases, and describes how this framework shapes her approach to treatment.

After experiencing her own health changes following vaccination — including hand tremors, fatigue, and skin conditions — Dr. Peers began exploring augmented NAC (N-acetyl cysteine) as part of the Zero Spike Project, led by researcher Fabio Zuffi.

She describes several compelling patient cases, including her own, where symptoms appeared to improve after starting the protocol. These include accounts of reduced neurological symptoms, improved cognitive clarity, and in one notable case, a significant reduction in seizure frequency. Dr. Peers is careful to note these are clinical observations, not controlled trial results, and that individual responses vary. She also shares the story of Michael, featured in the documentary “Why Can’t We Talk About This?”, whose slow recovery has been an encouraging development.

AIRDATE: April 9, 2026

As artificial intelligence technology expands at breakneck speed, so does the massive infrastructure required to power it. Jefferey Jaxen reports on a growing wave of communities pushing back against the rapid construction of AI data centers, facilities that require enormous amounts of electricity, computing power, and water to operate.

Local residents and officials in several regions say the projects are being approved with limited public discussion, even as concerns grow about rising energy demand, strained water resources, and long-term environmental impact. Some jurisdictions are now debating whether to slow or pause new data center development while the implications are more fully understood.

Behind the promise of AI innovation lies a largely unseen physical footprint. As technology companies race to build the next generation of computing infrastructure, communities are beginning to ask difficult questions about the real-world costs of the digital revolution.

AIRDATE: April 9, 2026

Is history repeating itself? Jefferey reveals a chilling, months-long pattern of government-issued “stay indoors” warnings spreading across America — and asks the question mainstream media refuses to: Is this really about air quality, or is it about controlling your behavior?

The EPA is pointing to PM 2.5 fine particulate matter in states including Arizona, California, and Oregon — toxins linked to cancer, cardiovascular disease, and neurological damage. But Jefferey digs deeper: these pollutants largely come from power plants, industries, and automobiles — so why are individuals being told to lock themselves inside instead of going after the source?

The study driving these alerts openly admits its goal is changing human behavior at scale. As Jaxen reveals, the researchers themselves ask: “How fast can we change people’s behavior?” Under the banner of climate change, fear-based messaging is being used to pressure Americans to drive less, change their diets, and comply — using the same carrot-and-stick psychology deployed during COVID lockdowns.

This is not a coincidence. This is a pattern. And you need to see it.

AIRDATE: April 9, 2026

Jefferey Jaxen reports on mounting concern over microplastics accumulating inside the human body, as HHS Director, Robert F. Kennedy Jr, announces a major new research effort to investigate the health implications of widespread plastic exposure. From drinking water to the air we breathe, scientists are detecting microscopic plastic particles in places few expected to find them, raising new questions about how modern environmental contamination may be interacting with human biology.

At the same time, a new controversy is emerging around blood transfusions and COVID vaccination status, as some patients begin requesting blood donations exclusively from unvaccinated donors. Blood banks insist the supply remains safe, but the requests reflect a growing public conversation about what remains in the bloodstream after both environmental and pharmaceutical exposures.

As these two stories unfold, Jefferey examines why the question of what’s circulating in the human body today is becoming increasingly concerning for researchers, regulators, and the public alike.

AIRDATE: April 9, 2026

Today on The HighWire, major questions are surrounding Climate Lockdowns, artificial intelligence expansion, and emerging treatments for COVID vaccine injury.

But first, HHS Secretary Robert F. Kennedy Jr. announces the launch of ‘The Secretary Kennedy Podcast,’ a new podcast where he will communicate directly with the public outside traditional media channels. He recently unveiled new federal action targeting microplastics contamination in drinking water, as concerns grow about plastic particles in the environment and the human body.

Then, Jefferey Jaxen reports on the accelerating expansion of artificial intelligence and the massive data center infrastructure needed to power it. As plans for data centers spread across the country, communities and states like Maine and Wisconsin are beginning to push back over the enormous water and energy demands required to support the AI boom.

Also, is our blood supply safe? We dive into the growing debate around blood donation policies following COVID-19 vaccination, and rising public concern about transparency within an already strained blood supply system.

Next, residents in several states are urged to stay indoors as air quality alerts spread amid rising pollution levels, prompting questions about whether these warnings reflect a genuine public health threat or something more.

Plus, Del sits down with Dr. Tina Peers to discuss her personal experience with COVID vaccine injury and the treatment protocols she has explored for spike protein-related illness.

Finally, chiropractor and Freedom Summit founder Dr. Jerod Ochsendorf joins the show to discuss the rapidly growing medical freedom movement and how patients and practitioners are building alternative health networks outside traditional institutions.

Guests: Dr. Tina Peers, Dr. Jerod Ochsendorf

Airdate: April 9, 2026

Lockdowns are back, just with a different justification. Toxic air warnings in Arizona and California are keeping people indoors and out of their communities. Is this a real public health response, or is it becoming another tool for control?

Then, the AI data center buildout is encountering resistance from an unexpected direction. States like Maine are pushing back, and their reasons go beyond politics.

And, Del sits down in-studio with Dr. Tina Peers, a functional medicine doctor who developed severe tremors and neuropathy following a COVID vaccine injury. Her recovery came through an augmented form of NAC, and the conversation about how it worked is one you won’t want to miss.

Tune in tomorrow!

The HighWire with Del Bigtree
📅April 9, 2026
⏰Thursday, 11AM PT | 2PM ET
📺Watch at: TheHighWire.com/WATCH

Nashville-born entrepreneur, philanthropist, and former MMA fighter Ed Clay joins Del to discuss his journey into regenerative medicine and the growing interest in stem cell therapies. Clay explains how his search for answers while helping his mother, who was suffering from an autoimmune condition and severe complications from conventional treatments, led him to explore emerging therapies outside the traditional medical system.

That search ultimately led Clay to help establish a regenerative medicine center in Mexico, where patients seek stem cell and immune-based treatments not widely available in the United States. He discusses the potential of regenerative medicine while also addressing the regulatory barriers and skepticism surrounding these therapies.

As interest in stem cell therapy and regenerative medicine continues to grow worldwide, Clay and Del explore the broader implications for medical innovation, patient choice, and the future of treatment options beyond conventional pharmaceuticals.

APRIL 2, 2026

Jefferey examines newly surfaced internal communications suggesting that messaging around potential stroke risks following COVID-19 vaccination may have been altered at the highest levels of government, including the Joe Biden White House. Drawing on reported emails from federal health agencies, the segment explores how language describing a “moderately elevated” safety signal was revised to “slightly elevated,” raising serious questions about transparency, public health communication, and risk disclosure during the vaccine rollout.

The analysis also highlights how terminology shifts, from “potential risk” to “preliminary signal”, may have softened public perception of adverse events at a critical moment when booster doses were being distributed to tens of millions of Americans. With coordinated messaging efforts involving the CDC, FDA, and select media and expert networks, the discussion frames these developments as part of a broader strategy to manage public response rather than fully inform it.

Beyond stroke-related concerns, the conversation expands into other reported safety signals, including myocarditis and cardiovascular stress markers observed in certain populations following vaccination. Internal deliberations and delayed public warnings are presented as evidence of systemic gaps in adverse event reporting and physician awareness, potentially impacting early detection and response to emerging risks.

Framed within the larger debate over censorship, government accountability, and medical transparency, Jefferey raises critical questions about how public health decisions are communicated—and who ultimately controls that narrative. As scrutiny intensifies over pandemic-era policies, the discussion underscores the importance of open scientific dialogue, rigorous safety monitoring, and restoring trust in public health institutions moving forward.

APRIL 2, 2026

Confidence in COVID-19 vaccines in the United States appears to be shifting, as new developments point to declining public engagement and demand. A halted clinical study by Pfizer and BioNTech—reportedly due to an inability to recruit enough participants—marks a rare moment where a widely recommended vaccine could not generate sufficient interest for ongoing research.

This trend aligns with broader declines in vaccine uptake following the peak of the COVID-19 pandemic, as fewer individuals pursue boosters and participation in follow-up studies drops. The slowdown is also impacting pharmaceutical markets, which are seeing reduced demand compared to earlier stages of the rollout.

The recruitment challenges highlight evolving public sentiment and may signal a turning point in how COVID-19 vaccines are perceived, studied, and integrated into future public health strategies.

APRIL 2, 2026